Shares of Abacus Life, Inc. (ABL) have gained 1.9% over the past four weeks to close the last trading session at $10.40, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 34.6%.The mean estimate comprises three short-term price targets with a standard deviation of $2. While the lowest estimate of $12 indicates a 15.4% increase from the current p ...